MoneyWorks4Me

Glaxosmithkline Pharmaceuticals board to consider unaudited financial results

17 Jul 2024 Evaluate
Glaxosmithkline Pharmaceuticals has informed that a meeting of the Board of Directors of the Company will be held on Friday, 2nd August 2024, to consider and approval of Un-audited financial results for the quarter ended 30th June 2024.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1855.00
Dr. Reddys Labs. 1147.20
Cipla 1359.00
Lupin 2046.00
Zydus Lifesciences 1110.20
View more..